[CRVS] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 45.70%
YoY- 4.19%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,701 -7,873 -8,297 -11,580 -12,935 -11,643 -14,301 -14.19%
Tax -20 923 884 -3 0 0 0 -
NP -5,701 -8,796 -9,181 -11,580 -12,935 -11,643 -14,301 -14.19%
Tax Rate - - - - - - - -
Total Cost 5,701 8,796 9,181 11,580 12,935 11,643 14,301 -14.19%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.12 -0.19 -0.20 -0.34 -0.44 -0.40 -0.63 -24.12%
EPS Diluted -0.12 -0.19 -0.20 -0.34 -0.44 -0.40 -0.63 -24.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.